SEC Form 4 · accession 0000914190-16-000727

Cardiovascular Systems Inc · CSII

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP Quality & Operations

Period of report

Feb 26, 2015

Accepted (ET)

Aug 10, 2016 · 6:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001180145

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2015	S	956	$38.7871	D	73,266	D
Common Stock^F1	Aug 8, 2016	A	23,881	$0.00	A	97,147	D
Common Stock^F2,F3	Aug 8, 2016	A	7,960	$0.00	A	106,652	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F4	$8.83	holding	—	—	—	—	Apr 17, 2017	Common Stock	35,585	35,585	D
Stock Option (right to buy)^F4	$8.83	holding	—	—	—	—	Apr 17, 2017	Common Stock	1,294	1,294	D
Stock Option (right to buy)^F4	$7.90	holding	—	—	—	—	Jun 11, 2017	Common Stock	8,087	8,087	D
Stock Option (right to buy)^F4	$7.90	holding	—	—	—	—	Oct 8, 2017	Common Stock	12,940	12,940	D
Stock Option (right to buy)^F4	$12.15	holding	—	—	—	—	Dec 11, 2017	Common Stock	32,350	32,350	D
Stock Option (right to buy)^F4	$8.75	holding	—	—	—	—	Mar 1, 2019	Common Stock	8,087	8,087	D

F1Subject to performance-based forfeiture based on the three year total shareholder return for fiscal years 2017, 2018 and 2019 versus the Company's peer group.
F2Restrictions lapse as to 2,654 shares on 8/13/17, and 2,653 shares on each of 8/13/18 and 8/13/19.
F3Includes 758 shares acquired on December 31, 2015 and 787 shares acquired on June 30, 2016 through the Issuer's Employee Stock Purchase Plan.
F4Fully exercisable.